We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOMO icon
851
Domo
DOMO
$172M
$162K 0.02%
21,635
-1,522
-7% -$11.6K
TVTX icon
852
Travere Therapeutics
TVTX
$5.2B
$161K 0.02%
+11,508
New +$120K
MYE icon
853
Myers Industries
MYE
$1.25B
$159K 0.02%
+11,519
New +$163K
WT icon
854
WisdomTree
WT
$2.95B
$153K 0.02%
+15,280
New +$155K
SOUN icon
855
SoundHound AI
SOUN
$2.73B
$151K 0.02%
+32,346
New +$156K
FF icon
856
Future Fuel
FF
$204M
$150K 0.02%
26,093
-4,466
-15% -$24.8K
CTOS icon
857
Custom Truck One Source
CTOS
$2.33B
$149K 0.02%
43,167
+7,212
+20% +$30.3K
DAWN
858
DELISTED
Day One Biopharmaceuticals
DAWN
$141K 0.02%
+10,107
New +$144K
APLT
859
DELISTED
Applied Therapeutics
APLT
$141K 0.02%
+16,531
New +$97.4K
TTI icon
860
TETRA Technologies
TTI
$1.06B
$141K 0.02%
45,324
+5,414
+14% +$17.5K
MDXG icon
861
MiMedx Group
MDXG
$660M
$133K 0.02%
22,587
-15,884
-41% -$105K
DENN
862
DELISTED
Denny's
DENN
$130K 0.02%
+20,109
New +$132K
IMMR icon
863
Immersion
IMMR
$253M
$130K 0.02%
14,527
-20,185
-58% -$205K
VTEX icon
864
VTEX
VTEX
$748M
$127K 0.02%
+17,044
New +$119K
NXE icon
865
NexGen Energy
NXE
$6.08B
$126K 0.02%
+19,256
New +$120K
LADR
866
Ladder Capital
LADR
$1.25B
$119K 0.01%
+10,299
New +$122K
AMCX icon
867
AMC Global Media
AMCX
$449M
$119K 0.01%
+13,726
New +$132K
TGB
868
Trekor Metals
TGB
$2.5B
$119K 0.01%
47,041
-49,687
-51% -$110K
CVRX icon
869
CVRx
CVRX
$132M
$118K 0.01%
13,418
+47
+0.4% +$427
LASR icon
870
nLIGHT
LASR
$3.53B
$116K 0.01%
+10,871
New +$123K
VET icon
871
Vermilion Energy
VET
$1.59B
$115K 0.01%
+11,771
New +$119K
DDD icon
872
3D Systems Corp
DDD
$412M
$108K 0.01%
+38,027
New +$109K
ZNTL icon
873
Zentalis Pharmaceuticals
ZNTL
$326M
$107K 0.01%
+29,191
New +$106K
PL icon
874
Planet Labs
PL
$7.26B
$107K 0.01%
+47,893
New +$106K
FFWM
875
DELISTED
First Foundation Inc
FFWM
$107K 0.01%
+17,111
New +$109K
33 34
35
36 37

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.